Concepedia

Maria Del Pilar Estevez-Diz

MD

Statistics

Publications

34

Citations

1.8K

H-Index

22

Active since

2002

Affiliations

Instituto do Câncer do Estado de São Paulo(Current)

Universidade de São Paulo

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Vall d'Hebron Institute of Oncology

Vall d'Hebron Hospital Universitari

Maria Del Pilar Estevez-Diz is an author at Instituto do Câncer do Estado de São Paulo specializing in medicine, obstetrics, and oncology.

ORCID

Top concepts

Publications per year

2002–2023

34

Publications

34

Transfusion Requirements in Surgical Oncology Patients

Juliano Pinheiro de Almeida, Jean‐Louis Vincent, Filomena Regina Barbosa Gomes Galas et al. · Anesthesiology · 2014 · 208 citations · Full text

Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial

Bradley J. Monk, Takafumi Toita, Xiaohua Wu et al. · The Lancet Oncology · 2023 · 182 citations

, , +10

Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer

David M. O’Malley, Ana Oaknin, Bradley J. Monk et al. · Gynecologic Oncology · 2021 · 127 citations · Full text

Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial

Samantha Cabral S. da Costa, Renata Colombo Bonadio, Flávia Carolina Grosso Gabrielli et al. · Journal of Clinical Oncology · 2019 · 118 citations

A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive <i>TP53</i> -mutant Ovarian Cancer

Amit M. Oza, Maria Del Pilar Estevez-Diz, Eva‐Maria Grischke et al. · Clinical Cancer Research · 2020 · 118 citations · Full text

Rows per page

1–5 of 34